Merck & Co., Inc. (MRK) Drops Development of Parkinson's Drug
5/24/2013 8:01:20 AM
More...
|
Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug
5/21/2013 6:46:06 AM
More...
|
Eli Lilly and Company (LLY) to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial
5/10/2013 7:52:32 AM
More...
|
CytRx Corporation (CYTR) Ditches Lung Cancer Drug After Phase 2 Trial Failure
5/8/2013 10:48:49 AM
More...
|
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns
5/6/2013 8:37:54 AM
More...
|
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy
4/18/2013 7:56:51 AM
More...
|
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt
4/4/2013 8:04:52 AM
More...
|
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML
4/2/2013 7:56:18 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Cancer Drug Fails in Late-Stage Trial; Shares Plunge
3/26/2013 7:20:32 AM
More...
|
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study
3/20/2013 7:35:54 AM
More...
|
Pfizer Inc. (PFE) Halts Development of Hepatitis C Drug
3/11/2013 8:13:20 AM
More...
|
AEterna Zentaris (AEZS) to Discontinue Phase 3 Trial in Multiple Myeloma With Perifosine
3/11/2013 11:34:36 AM
More...
|
Moberg Derma Discontinues Clinical Development of Limtop
3/11/2013 11:08:05 AM
More...
|
FDA Halts Amgen (AMGN) Trial After Teen Death
2/27/2013 7:58:45 AM
More...
|
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug
2/12/2013 7:45:04 AM
More...
|
|